Plasma Brain-Derived Neurotrophic Factor and Psychopathology in Attempted Suicide

Neuropsychobiology

Volumn 73, Issue 4, 2016, Pages 241-248

  Ambrus, Livia ^a   Sunnqvist, Charlotta ^b   Ekman, Rolf ^c   Träskman Bendz, Lil ^a   Westrin, Åsa ^a  

^a LUND UNIVERSITY   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Brain derived neurotrophic factor; Psychopathology; Suicide

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

ADULT; ANXIETY ASSESSMENT; ARTICLE; BRIEF SCALE FOR ANXIETY; COMPREHENSIVE PSYCHOPATHOLOGICAL RATING SCALE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MARKE NYMAN TEMPERAMENT SCALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PERSONALITY; PERSONALITY ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SOLIDITY; SUICIDE ATTEMPT; ADJUSTMENT DISORDER; AGED; ANXIETY DISORDER; BLOOD; IMPULSIVENESS; MENTAL DISEASE; MIDDLE AGED; MOOD DISORDER; PSYCHOLOGY; PSYCHOSIS; TEMPERAMENT; YOUNG ADULT;

ADJUSTMENT DISORDERS; ADULT; AGED; ANXIETY DISORDERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; IMPULSIVE BEHAVIOR; MALE; MENTAL DISORDERS; MIDDLE AGED; MOOD DISORDERS; PERSONALITY; PSYCHOTIC DISORDERS; SUICIDE, ATTEMPTED; TEMPERAMENT; YOUNG ADULT;

EID: 84976313480     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000446286     Document Type: Article

References (52)

1. Huang EJ, Reichardt LF: Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001; 24:677-736.
2. Dwivedi Y: Brain-derived neurotrophic factor and suicide pathogenesis. Ann Med 2010; 42:87-96.
3. Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN: Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60:804-815.
4. Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R: Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005; 136:29-37.
5. Grah M, Mihanovic M, Ruljancic N, Restek-Petrovic B, Molnar S, Jelavic S: Brain-derived neurotrophic factor as a suicide factor in mental disorders. Acta Neuropsychiatr 2014; 26: 356-363.
6. Brunoni AR, Lopes M, Fregni F: A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11:1169-1180.
7. Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F: Brain-derived neu-rotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 2011; 45:995-1004.
8. Nurjono M, Lee J, Chong SA: A review of brain-derived neurotrophic factor as a candidate biomarker in schizophrenia. Clin Psy-chopharmacol Neurosci 2012; 10:61-70.
9. Kim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, Lee SW, Yoon D, Han C, Kim DJ, Choi SH: Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:78-85.
10. Diefenbach GJ, Woolley SB, Goethe JW: The association between self-reported anxiety symptoms and suicidality. J Nerv Ment Dis 2009; 197:92-97.
11. Terracciano A, Martin B, Ansari D, Tanaka T, Ferrucci L, Maudsley S, Mattson MP, Costa PT Jr: Plasma BDNF concentration, Val-66Met genetic variant and depression-related personality traits. Genes Brain Behav 2010; 9: 512-518.
12. Lang UE, Hellweg R, Gallinat J: BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology 2004; 29: 795-798.
13. Minelli A, Zanardini R, Bonvicini C, Sartori R, Pedrini L, Gennarelli M, Bocchio-Chiavet-to L: BDNF serum levels, but not BDNF Val-66Met genotype, are correlated with personality traits in healthy subjects. Eur Arch Psychiatry Clin Neurosci 2011; 261:323-329.
14. Yasui-Furukori N, Tsuchimine S, Kaneda A, Sugawara N, Ishioka M, Kaneko S: Association between plasma brain-derived neuro-trophic factor levels and personality traits in healthy Japanese subjects. Psychiatry Res 2013; 210:220-223.
15. Terracciano A, Lobina M, Piras MG, Mulas A, Cannas A, Meirelles O, Sutin AR, Zonder-man AB, Uda M, Crisponi L, Schlessinger D: Neuroticism, depressive symptoms, and serum BDNF. Psychosom Med 2011; 73:638-642.
16. Okuno K, Yoshimura R, Ueda N, Ikenouchi-Sugita A, Umene-Nakano W, Hori H, Hayas-hi K, Katsuki A, Chen HI, Nakamura J: Relationships between stress, social adaptation, personality traits, brain-derived neurotrophic factor and 3-methoxy-4-hydroxyphenylgly-col plasma concentrations in employees at a publishing company in Japan. Psychiatry Res 2011; 186:326-332.
17. Brezo J, Paris J, Turecki G: Personality traits as correlates of suicidal ideation, suicide attempts, and suicide completions: a systematic review. Acta Psychiatr Scand 2006; 113:180-206.
18. Pan W, Banks WA, Fasold MB, Bluth J, Kastin AJ: Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuro-pharmacology 1998; 37:1553-1561.
19. Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, Mahadik SP: Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. Int J Neuropsy-chopharmacol 2010; 13:535-539.
20. Klein AB, Williamson R, Santini MA, Clem-mensen C, Ettrup A, Rios M, Knudsen GM, Aznar S: Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 2011; 14:347-353.
21. Mann JJ: Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4:819-828.
22. Beck AT, Davis J, Frederick, CJ, Perlin S, Po-korny A, Schulman R, Seiden R, Wittlin B: Classification and nomenclature; in Resnik HPL, Hathorne B (eds): Suicide Prevention in the Seventies. Washington, US Government Printing Office, 1972.
23. American Psychiatric Association: Diagnostics and Statistical Manual of Mental Disorders, ed 3 rev. Washington, American Psychiatric Association, 1987.
24. Asberg M, Montgomery SA, Perris C, Schal-ling D, Sedvall G: A comprehensive psycho-pathological rating scale. Acta Psychiatr Scand Suppl 1978; 271:25-27.
25. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
26. Tyrer P, Owen RT, Cicchetti DV: The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale. J Neurol Neurosurg Psychiatry 1984; 47:970-975.
27. Nyman GE, Marke S: The Differential Psychology of Sjöbring (in Swedish with an English summary). Lund, Gleerups, 1962.
28. Huang MC, Chen CH, Chen CH, Liu SC, Ho CJ, Shen WW, Leu SJ: Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol 2008; 43:241-245.
29. Corominas-Roso M, Roncero C, Eiroa-Orosa FJ, Gonzalvo B, Grau-Lopez L, Ribases M, Ro-driguez-Cintas L, Sánchez-Mora C, Ramos-Quiroga JA, Casas M: Brain-derived neuro-trophic factor serum levels in cocaine-dependent patients during early abstinence. Eur Neuropsychopharmacol 2013; 23:1078-1084.
30. Huang MC, Chen CH, Liu HC, Chen CC, Ho CC, Leu SJ: Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal. Alcohol Clin Exp Res 2011; 35:126-131.
31. Ren W, Tao J, Wei Y, Su H, Zhang J, Xie Y, Guo J, Zhang X, Zhang H, He J: Time-dependent serum brain-derived neurotrophic dac-tor decline during methamphetamine withdrawal. Medicine (Baltimore) 2016; 95:e2604.
32. Rydin E, Asberg M, Edman G, Schalling D: Violent and nonviolent suicide attempts-a controlled Rorschach study. Acta Psychiatr Scand 1990; 82:30-39.
33. Sjöbring H: Personality Structure and Development. Copenhagen, Munksgaard, 1973.
34. Coppen A: The Marke-Nyman temperament scale: an English translation. Br J Med Psychol 1966; 39:55-59.
35. Eysenck HJ, Eysenck SBG: Manual of the Ey-senck Personality Questionnaire. London, Hodder and Stoughton, 1975.
36. Segraves RT: Intercorrelations between the Sjöbring and Eysenckian personality dimensions. Acta Psychiatr Scand 1971; 47:288-294.
37. Beck AT, Davis J, Frederick, CJ, Perlin S, Po-korny A, Schulman R, Seiden R, Wittlin B: Classification and nomenclature; in Resnik HPL, Hathorne B (eds): Suicide Prevention in the Seventies. Washington, US Government Printing Office, 1972.
38. Schalling D, Asberg M: Biological and psychological correlates of impulsiveness and monotony avoidance; in Strelau J, Farley FH, Gale A (eds): The Biological Bases of Personality and Behavior: Theories, Measurement Techniques, and Development. Washington, Hemisphere, 1985, vol 1, pp 181-194.
39. Gvion Y, Apter A: Aggression, impulsivity, and suicide behavior: a review of the literature. Arch Suicide Res 2011; 15:93-112.
40. Zörner B, Wolfer DP, Brandis D, Kretz O, Zacher C, Madani R, Grunwald I, Lipp HP, Klein R, Henn FA, Gass P: Forebrain-specific trkB-receptor knockout mice: behaviorally more hyperactive than 'depressive'. Biol Psychiatry 2003; 54:972-982.
41. Kim H, Heo HI, Kim DH, Ko IG, Lee SS, Kim SE, Kim BK, Kim TW, Ji ES, Kim JD, Shin MS, Choi YW, Kim CJ: Treadmill exercise and methylphenidate ameliorate symptoms of attention deficit/hyperactivity disorder through enhancing dopamine synthesis and brain-derived neurotrophic factor expression in spontaneous hypertensive rats. Neurosci Lett 2011; 504:35-39.
42. Duclot F, Kabbaj M: Individual differences in novelty seeking predict subsequent vulnerability to social defeat through a differential epigenetic regulation of brain-derived neuro-trophic factor expression. J Neurosci 2013; 33: 11048-11060.
43. Lee BH, Kim H, Park SH, Kim YK: Decreased plasma BDNF level in depressive patients. J Affect Disord 2007; 101:239-244.
44. Zhang J, Zhang X, Su H, Tao J, Xie Y, Han B, Lu Y, Wei Y, Sun H, Wang Y, Wu W, Zou S, Liang H, Zoghbi AW, Tang W, He J: Increased serum brain-derived neurotrophic factor levels during opiate withdrawal. Neu-rosci Lett 2014; 571:6.
45. Bhang SY, Kim K, Choi SW, Ahn JH: Do levels of brain-derived neurotrophic factor (BDNF) in plasma correlate with psychopa-thology in healthy subjects? Neurosci Lett 2012; 512:72-77.
46. Huang T, Larsen KT, Ried-Larsen M, Møller NC, Andersen LB: The effects of physical activity and exercise on brain-derived neuro-trophic factor in healthy humans: a review. Scand J Med Sci Sports 2014; 24:1-10.
47. Pluchino N, Cubeddu A, Begliuomini S, Mer-lini S, Giannini A, Bucci F, Casarosa E, Luisi M, Cela V, Genazzani AR: Daily variation of brain-derived neurotrophic factor and cortisol in women with normal menstrual cycles, undergoing oral contraception and in postmeno-pause. Hum Reprod 2009; 24:2303-2309.
48. Zuccato C, Marullo M, Vitali B, Tarditi A, Mariotti C, Valenza M, Lahiri N, Wild EJ, Sassone J, Ciammola A, Bachoud-Lèvi AC, Tabrizi SJ, Di Donato S, Cattaneo E: Brain-derived neurotrophic factor in patients with Huntington's disease. PLoS One 2011; 6:e22966.
49. Begliuomini S, Lenzi E, Ninni F, Casarosa E, Merlini S, Pluchino N, Valentino V, Luisi S, Luisi M, Genazzani AR: Plasma brain-derived neurotrophic factor daily variations in men: correlation with cortisol circadian rhythm. J Endocrinol 2008; 197:429-435.
50. Dalley JW, Roiser JP: Dopamine, serotonin and impulsivity. Neuroscience 2012; 215:42-58.
51. Ryding E, Ahnlide JA, Lindström M, Rosén I, Träskman-Bendz L: Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res 2006; 148: 195-203.
52. Homberg JR: The serotonin-BDNF duo: developmental implications for the vulnerability to psychopathology. Neurosci Biobehav Rev 2014; 43:35-47.